Wilson Sonsini Goodrich & Rosati advised Trutino Biosciences on the deal. Boehringer Ingelheim, a leading research-driven biopharmaceutical company, announced the signing of an option to acquire […]
Boehringer Ingelheim’s Acquisition of Trutino Biosciences
Infinitum Electric’s $80 Million Series D Funding
Vinson & Elkins advised Riverstone Holdings LLC on the deal while Wilson Sonsini represented Infinitum Electric. Riverstone Holdings LLC acted as lead investor in Infinitum Electric’s […]
Simcha Therapeutics’ $40 Million Series B Financing
Wilson Sonsini Goodrich & Rosati advised SR One on the deal. Simcha Therapeutics, a biotechnology company developing cytokine-based cancer immunotherapies, announced the closing of a $40 […]
Attralus’ $116 Million Series B Financing
Wilson Sonsini Goodrich & Rosati advised Logos Capital on the deal while Sidley represented Attralus, Inc. Attralus, Inc., a clinical stage biopharmaceutical company developing transformative medicines […]